Clinical Trial Update: Combined Inhalational With Intravenous Amphotericin B Versus Intravenous Amphotericin B Alone for Pulmonary Mucormycosis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing inhalational plus intravenous amphotericin B versus intravenous amphotericin B alone for pulmonary mucormycosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Mucormycosis

Drugs mentioned

• Amphotericin B (Amphotericin B)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Pulmonary Mucormycosis | Phase 2 | Status: COMPLETED